Heron Therapeutics | HRTX - Ebit

주가
0.80
매일 변경
0.04 4.58%
매월
-33.33%
매년
-65.07%
Q1 예상
0.76




Ebit 변화 날짜
ALKERMES USD -10.95M 100.03M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amarin USD -2.26M 564K 2025-12
ANI Pharmaceuticals USD 29.13M 6.3M 2025-12
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD 40.81M 17.01M 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -249.71M 11.64M 2025-12
Ligand Pharmaceuticals USD 158.89M 115.32M 2025-09
Merck USD 6.24B 1.32B 2025-12
Nektar Therapeutics USD -34.34M 3.68M 2024-09
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Omeros USD -48.15M 7.25M 2023-09
Pacira USD 3.19M 9.96M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Surmodics USD -322K 2.13M 2023-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Veracyte USD 24.63M 1.52M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12